🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Early Stage Lung Non-Small Cell Carcinoma

To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer NCT07195084NA1 site📍 Hefei Anhui Provincial Cancer Hospital · Tests: Hypervision proton surgery Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT NCT05623267Phase 2, Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Sugemalimab, Placebo The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer NCT07008742n/a1 site📍 London Royal Marsden NHS Foundation Trust A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab NCT07391670Phase 119 sites📍 Fitzroy📍 St Albans📍 Woolloongabba AstraZeneca · Tests: SC durvalumab + rHu, IV durvalumab, Tremelimumab Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer NCT07432802NA4 sites📍 Copenhagen📍 Aalborg📍 Aarhus N Aarhus University Hospital · Tests: Stereotactic radiation therapy intervention, Surgical intervention Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients NCT04980716Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Multiple cardiovascular drugs related to "Golden Triangle" Synapse 3D With Intravascular Indocyanine Green NCT03953144Phase 1, Phase 21 site📍 Hamilton St. Joseph's Healthcare Hamilton · Tests: Synapse 3D Lung Modelling, IC-Green (ICG) Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer NCT03546829Phase 11 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Vancomycin, Precision hypofractionated radiation Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial NCT07388524Phase 3110 sites📍 Beverly Hills📍 Los Angeles📍 Tarzana National Cancer Institute (NCI) · Tests: Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection, Computed Tomography, Patient Ob… Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations NCT07195695Phase 3202 sites📍 Fresno📍 Glendale📍 Orange Boehringer Ingelheim · Tests: Zongertinib, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy NCT07010263Phase 353 sites📍 Beijing📍 Beijing📍 Beijing Akeso · Tests: AK112, Placebo Multiomics Tumor Evolution Model of NSCLC NCT05352035n/a1 site📍 Beijing Peking University People's Hospital Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy NCT03042221n/a1 site📍 Aurora University of Colorado, Denver A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced NCT06467383n/a25 sites📍 San Giovanni Rotondo📍 Brescia📍 Campobasso MSD Italia S.r.l. Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway NCT07649629n/a1 site📍 Roma Regina Elena Cancer Institute · Tests: Plasma-based liquid biopsy Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients NCT07242547Phase 220 sites📍 Albacete📍 Alicante📍 Elche Fundación GECP · Tests: Tarlatamab Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field NCT04944563NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Segmentectomy, Lobectomy Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy NCT07257471n/a1 site📍 Beijing Beijing Haidian Hospital A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease NCT07323732Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: BIO 300 Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data NCT07743021n/a33 sites📍 Balatonfüred📍 Békéscsaba📍 Budapest Center for Molecular Fingerprinting Research Nonprofit LLC A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. NCT06284317Phase 342 sites📍 Camperdown📍 Penrith📍 St Leonards ETOP IBCSG Partners Foundation · Tests: Adjuvant durvalumab Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes NCT06699979n/a1 site📍 Changsha Central South University Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer NCT07412327NA1 site📍 Guangzhou Guangzhou Concord Cancer Center · Tests: Stereotactic Body Proton Therapy Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer NCT06566443Phase 11 site📍 Houston The Methodist Hospital Research Institute · Tests: Honokiol Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases NCT06542159Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Online adaptive SBRT, Conventional SBRT ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer NCT06902272Phase 21 site📍 Miami University of Miami · Tests: Circulating Tumor Deoxyribonucleic acid (ctDNA) Assay, Pembrolizumab, Platinum Doublet Chemotherapy A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection NCT07128199Phase 3253 sites📍 Anchorage📍 Duarte📍 Irvine Taiho Oncology, Inc. · Tests: TAS6417, Zipalertinib Matching-placebo Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer NCT03706027NA1 site📍 Rochester University of Rochester · Tests: radiation therapy-3 fractions, Radiation therapy-5 fractions Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy NCT06862869n/a44 sites📍 Zhanjiang📍 Guangzhou📍 Kaifeng Hoffmann-La Roche · Tests: Alectinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy